Cellectar Biosciences, Inc. (CLRB)
NASDAQ·Healthcare·Biotechnology
$1.20
-0.83%
Mkt Cap $8.78M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+816.7%
Consensus $11.00 vs current $1.20
NASDAQ·Healthcare·Biotechnology
$1.20
-0.83%
Mkt Cap $8.78M
No recent rating data.
Price Target (2 analysts)
$11.00
Range $11.00 – $11.00
+816.7%
Consensus $11.00 vs current $1.20